Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 893-903

  Denkert, Carsten ^a   Köbel, Martin ^a   Pest, Sören ^b   Koch, Ines ^a   Berger, Stefan ^a   Schwabe, Michael ^a   Siegert, Antje ^a   Reles, Angela ^a   Klosterhalfen, Bernd ^c   Hauptmann, Steffen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1BETA; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PHORBOL ESTER; PROSTAGLANDIN E2;

ARTICLE; ASCITES; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTADENOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION;

EID: 0036124320     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64912-7     Document Type: Article

References (51)

1. Cancer statistics
2. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
3. Aspirin use and reduced risk of fatal colon cancer
4. Aspirin use and lung, colon and breast cancer incidence in a prospective study
5. Cyclooxygenase inhibitors in tumorigenesis (part I)
6. Cyclooxygenase inhibitors in tumorigenesis (part II)
7. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
8. Suppression of intestinal polyposis in Apc knockout mice by inhibition of cyclooxygenase 2 (COX-2)
9. Cyclooxygenase-2 expression is upregulated in human pancreatic cancer
10. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
11. Expression of cyclooxygenase-2 in human lung carcinoma
12. Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck
13. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
14. Multiple female reproductive failures in cyclooxygenase 2 deficient mice
15. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
16. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors
17. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary
18. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin
19. Expression of cyclooxygenase-2 in prostate carcinoma
20. Toward the development of a universal grading system for ovarian epithelial carcinoma
21. Expression of Cyclooxygenase-2 in human transitional carcinoma of the urinary bladder
22. Expression of cyclooxygenase-2 in human gastric carcinoma
23. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas
24. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages
25. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms
26. Prostaglandins E in primary tumor, metastases and ascitic fluid of patients with ovarian cancer
27. Formation of prostaglandins by ovarian carcinomas
28. The regulation by ovarian steroids of prostaglandin synthesis and prostaglandin-induced contractility in non-pregnant rat myometrium. Modulating effects of isoproterenol
29. Effect of hormonal status on the expression of the cyclooxygenase 1 and 2 genes and prostaglandin synthesis in rat mammary glands
30. The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase C
31. Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon-tau in bovine endometrial cells
32. Over-the counter analgesics and ovarian cancer
33. Aspirin and ovarian cancer: An Italian case-control study
34. A case-control study of analgesic use and ovarian cancer
35. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells
36. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
37. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
38. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Upregulation of interleukin 10 and down-regulation of interleukin 12 production
39. Cyclooxygense-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
40. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients
41. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer
42. Different features of angiogenesis between ovarian and breast carcinoma
43. Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum
44. Apoptotic index in ovarian carcinoma: Correlation with clinicopathologic factors and prognosis
45. p53 and related proteins in epithelial ovarian cancer
46. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
47. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
48. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
49. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
50. Recent advances in chemoprevention of cancer